On Neurodegenerative Diseases, Models, and Treatment Strategies: Lessons Learned and Lessons Forgotten a Generation Following the Cholinergic Hypothesis

Bartus, Raymond T.·2000·Experimental Neurology

Cites (231)

Items 201–229 of 229

  1. Rational design of an animal model for alzheimer's disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent
    Jeanne F. Loring, Chris Pászty, Avidan Rose, Tracy K. McIntosh, Hisayuki Murai, Jean E.S. Pierce, Stephen R. Schramm, Kathryn Wymore, Virginia M.‐Y. Lee, John Q. Trojanowski et al. · 1996 · Neurobiology of Aging
  2. Effect of tetrahydrocannabinols on brain acetylcholine
    William E. Askew, Aubrey P. Kimball, Beng T. Ho · 1974 · Brain Research
  3. Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
    Pierre N. Tariot · 1997 · Archives of Neurology
  4. Senile dementia of the Alzheimer type
    W. Gary Erwin · 1984 · American Journal of Health-System Pharmacy
  5. Pharmacological treatment of Alzheimer's disease : molecular and neurobiological foundations
    Jorge D. Brioni, Michael W. Decker · 1997 · Wiley-Liss eBooks
  6. Clinical Heterogeneity
    Sarah A. Eagger, Richard J. Harvey · 1995 · Alzheimer Disease & Associated Disorders
  7. Psychometric Discrimination of Tetrahydroaminoacridine Responders in Alzheimer Patients
    Kari Alhainen, Eeva‐Liisa Helkala, Paavo J. Riekkinen · 1993 · Dementia and Geriatric Cognitive Disorders
  8. Treatment of age-associated memory impairment with guanfacine.
    William J. McEntee, Crook Th, L. R. Jenkyn, William M. Petrie, Glenn J. Larrabee, David Coffey · 1991 · PubMed
  9. Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease.
    Ganlu Lou, Patrick R. Montgomery, DANIEL S. SITAR · 1996 · PubMed
  10. Animal and Human Memory Dysfunctions Associated with Aging, Cholinergic Lesions, and Senile Dementia
    Charles Flicker, Reginald L. Dean, Raymond T. Bartus, Steven H. Ferris, Thomas H. Crook · 1985 · Annals of the New York Academy of Sciences
  11. Lack of efficacy of clonidine on memory in aged cebus monkeys
    Raymond T. Bartus, Reginald L. Dean · 1988 · Neurobiology of Aging
  12. Therapy for Alzheimer's disease
    Ezio Giacobini · 1994 · Molecular Neurobiology
  13. Noradrenergic intervention in Alzheimer's disease.
    T. H. Crook, Elliot Wilner, Andrew Rothwell, D. WINTERLING, William J. McEntee · 1992 · PubMed
  14. Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels
    Lars Clemmesen, P. L. Mikkelsen, H. Lund, Tom G. Bolwig, Ole J. Rafaelsen · 1984 · Psychopharmacology
  15. Aging and spatial cognition
    David S. Olton · 1988 · Neurobiology of Aging
  16. A Pilot Study of Clonidine Plus Physostigmine in Alzheimer's Disease
    Linda M. Bierer, Paul S. S. Aisen, Michael H. Davidson, Theresa M. Ryan, James Schmeidler, Kenneth L. Davis · 1994 · Dementia and Geriatric Cognitive Disorders
  17. CONFERENCE ON THE AGEING BRAIN
    C. M. Smith, Michael Swash · 1979 · Age and Ageing
  18. Future therapeutic approaches to Alzheimer's disease.
    Kenneth L. Davis · 1998 · PubMed
  19. Letter to the editor
    Elaine Perry, D IRVING, R PERRY · 1991 · Trends in Neurosciences
  20. Evidence that perihypoglossal neurons involved in vestibular-auditory and gaze control functions respond to nerve growth factor
    Renat R. Sukhov, Michelle H. Cayouette, Monte J. Radeke, Stuart C. Feinstein, Deborah Blumberg, Arnon Rosenthal, Donald L. Price, Vassilis E. Koliatsos · 1997 · The Journal of Comparative Neurology
  21. Neural circuitry underlying behavioral deficits in aging
    Mortimer Mishkin · 1993 · Neurobiology of Aging
  22. What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia?
    Irene Litvan, Angela Sirigu B, J. Toothman, Jordan Henry Grafman · 1995 · Neurology
  23. Penetration of Tacrine Into Cerebrospinal Fluid in Patients With Alzheimer's Disease
    Dale R. Grothe, Stephen C. Piscitelli, Ruth A. Dukoff, Terrence Fullerton, Trey Sunderland, Susan E. Molchan · 1998 · Journal of Clinical Psychopharmacology
  24. Cholinergic controversies
    Rosalind M. Ridley, H. F. Baker, A FINE · 1991 · Trends in Neurosciences
  25. New Directions in Understanding Dementia and Alzheimer’s Disease
    Taher Zandi, Richard J. Ham · 1990 · Advances in experimental medicine and biology
  26. Cholinomimetic Agents and Human Memory: Preliminary Observations in Alzheimer’s Disease
    Kenneth L. Davis, Richard C. Mohs, Belinda Jane Davis, Gordon S. Rosenberg, Thomas Horvath, Yvonne DeNigris · 1981 · Advances in behavioral biology
  27. Pharmacological Treatment of Alzheimer’s Disease
    Clive G. Ballard, Susanne Sorensen, Dag Aarsland, Alzheimer’s Society, London · 2008 · European Neurological Review
  28. Neurotransmitter Interactions and Responsivity to Cholinomimetic Agents
    Vahram H. Haroutunian, Annalisa Santucci, Kenneth L. Davis · 1992 · Birkhäuser Boston eBooks
  29. On Possible Relationships between Alzheimer’s Disease, Age-Related Memory Loss and the Development of Animal Models
    Raymond T. Bartus, Reginald L. Dean · 1987 · Springer eBooks